Chronic effects of blast injury on the microvasculature in a transgenic mouse model of Alzheimer's disease related Aβ amyloidosis

被引:9
|
作者
Clark, Alexander T. [2 ]
Abrahamson, Eric E. [1 ,2 ]
Harper, Matthew M. [4 ,5 ]
Ikonomovic, Milos D. [1 ,2 ,3 ]
机构
[1] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Univ Dr C, Pittsburgh, PA 15240 USA
[2] Univ Pittsburgh, Dept Neurol, Sch Med, 3471 Fifth Ave, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Dept Psychiat, Sch Med, Thomas Detre Hall WPH,Room 1421,3811 Ohara St, Pittsburgh, PA 15213 USA
[4] Iowa City VA Ctr Prevent & Treatment Visual Loss, 601 Hwy 6 West, Iowa City, IA 52246 USA
[5] Univ Iowa, Dept Ophthalmol & Visual Sci & Biol, 200 Hawkins Dr, Iowa City, IA 52242 USA
关键词
Alzheimer's disease; Amyloid; Astrocyte; Blast injury; Blood-brain barrier; NVU; Neurovascular unit; Pericyte; Traumatic brain injury; BLOOD-BRAIN-BARRIER; EXPERIMENTAL RODENT MODEL; GANGLION-CELL DAMAGE; HIPPOCAMPAL MICROVASCULATURE; NEUROVASCULAR DYSFUNCTION; CAPILLARY PERICYTES; SENILE PLAQUES; FLOW; AGE; DISRUPTION;
D O I
10.1186/s12987-021-00301-z
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Altered cerebrovascular function and accumulation of amyloid-beta (A beta) after traumatic brain injury (TBI) can contribute to chronic neuropathology and increase the risk for Alzheimer's disease (AD). TBI due to a blast-induced shock wave (bTBI) adversely affects the neurovascular unit (NVU) during the acute period after injury. However, the chronic effects of bTBI and A beta on cellular components of the NVU and capillary network are not well understood. Methods: We exposed young adult (age range: 76-106 days) female transgenic (Tg) APP/PS1 mice, a model of AD-like A beta amyloidosis, and wild type (Wt) mice to a single bTBI (similar to 138 kPa or similar to 20 psi) or to a Sham procedure. At 3-months or 12-months survival after exposure, we quantified neocortical A beta load in Tg mice, and percent contact area between aquaporin-4 (AQP4)-immunoreactive astrocytic end-feet and brain capillaries, numbers of PDGFR beta-immunoreactive pericytes, and capillary densities in both genotypes. Results: The astroglia AQP4-capillary contact area in the Tg-bTBI group was significantly lower than in the Tg-Sham group at 3-months survival. No significant changes in the AQP4-capillary contact area were observed in the Tg-bTBI group at 12-months survival or in the Wt groups. Capillary density in the Tg-bTBI group at 12-months survival was significantly higher compared to the Tg-Sham control and to the Tg-bTBI 3-months survival group. The Wt-bTBI group had significantly lower capillary density and pericyte numbers at 12-months survival compared to 3-months survival. When pericytes were quantified relative to capillary density, no significant differences were detected among the experimental groups, for both genotypes. Conclusion: In conditions of high brain concentrations of human A beta, bTBI exposure results in reduced AQP4 expression at the astroglia-microvascular interface, and in chronic capillary proliferation like what has been reported in AD. Long term microvascular changes after bTBI may contribute to the risk for developing chronic neurodegenerative disease later in life.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Comorbidity of anxiety and Alzheimer's disease in the triple transgenic mouse model
    Varkonyi, Dorottya
    Sipos, Eszter
    Torok, Bibiana
    Zelena, Dora
    JOURNAL OF NEURAL TRANSMISSION, 2021, 128 (11) : 1781 - 1781
  • [42] BEHAVIORAL AND PATHOLOGICAL CHANGES IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE
    Dong Xian-hui
    Gao Wei-juan
    Kong Wei-na
    Chai Xi-qing
    INDIAN JOURNAL OF ANIMAL RESEARCH, 2014, 48 (04) : 389 - 394
  • [43] Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
    Bourasset, Fanchon
    Ouellett, Melissa
    Tremblay, Cyntia
    Julien, Carl
    Do, Tuan Minh
    Oddo, Salvatore
    LaFerla, Frank
    Calon, Frederic
    NEUROPHARMACOLOGY, 2009, 56 (04) : 808 - 813
  • [44] Degradation of Bone Quality in a Transgenic Mouse Model of Alzheimer's Disease
    LLabre, Joan E.
    Gil, Cristianel
    Amatya, Neha
    Lagalwar, Sarita
    Possidente, Bernard
    Vashishth, Deepak
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (12) : 2548 - 2565
  • [45] Intracerebroventricular passive immunization in transgenic mouse model of Alzheimer's disease
    Chauhan, NB
    Lichtor, T
    Siegel, GJ
    NEUROBIOLOGY OF AGING, 2004, 25 : S577 - S577
  • [46] Distinct microrna expression in a transgenic mouse model of Alzheimer's disease
    Ryan, M.
    Mockett, B.
    Guevremont, D.
    Abraham, W.
    WIlliams, J.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 328 - 328
  • [47] Genetics of amyloid metabolism in a transgenic mouse model of Alzheimer's disease
    Ryman, D
    GERONTOLOGIST, 2004, 44 : 20 - 20
  • [48] Metabonomic Profiling of TASTPM Transgenic Alzheimer's Disease Mouse Model
    Hu, Ze-Ping
    Browne, Edward R.
    Liu, Tao
    Angel, Thomas E.
    Ho, Paul C.
    Chan, Eric Chun Yong
    JOURNAL OF PROTEOME RESEARCH, 2012, 11 (12) : 5903 - 5913
  • [49] Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease
    Knight, Elysse M.
    Verkhratsky, Alexei
    Luckman, Simon M.
    Allan, Stuart M.
    Lawrence, Catherine B.
    NEUROBIOLOGY OF AGING, 2012, 33 (01) : 187 - 193
  • [50] Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease
    Yu, Dongzi
    Corbett, Brian
    Yan, Yaping
    Zhang, Guang-Xian
    Reinhart, Peter
    Cho, Seongeun J.
    Chin, Jeannie
    NEUROBIOLOGY OF AGING, 2012, 33 (12) : 2942 - 2947